<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1044">
  <stage>Registered</stage>
  <submitdate>25/01/2006</submitdate>
  <approvaldate>27/01/2006</approvaldate>
  <actrnumber>ACTRN12606000043538</actrnumber>
  <trial_identification>
    <studytitle>Effect of epidural adenosine and neostigmine on postoperative pain status</studytitle>
    <scientifictitle>A randomised study to evaluate the effect of epidural adenosine and neostigmine in patients undergoing abdominal surgery to improve postoperative pain status.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Epidural adenosine and neostigmine for 4 hours given as intravenous injections over 12 weeks</interventions>
    <comparator />
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Postoperative pain scores</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Plasma level of cortisol </outcome>
      <timepoint>During and after surgery.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing lower abdominal surgery for benign gynecological disease.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed envelope assignment</concealment>
    <sequence>blocking and sealed envelope assignment</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Japan</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Eiji Masaki</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Ministry of Education, Science, Sport and Culture of Japan</fundingname>
      <fundingaddress />
      <fundingcountry>Japan</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Kazuhiro Shoji</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To examine whether the epidural adenosine enhance the antinociceptive effect of neostigmine, we evaluated the effect of epidural co-administration of neostigmine and adenosine in patients undergoing abdominal surgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Eiji Masaki</name>
      <address>Department of Anesthesiology
Saitama Medical School
38 Morohongo Moroyama-cho Iruma-gun
Saitama 350-0451</address>
      <phone>+81 49 2761270</phone>
      <fax />
      <email>ejmasaki@saitama-med.ac.jp</email>
      <country>Japan</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Eiji Masaki</name>
      <address>Department of Anesthesiology
Saitama Medical School
38 Morohongo Moroyama-cho Iruma-gun
Saitama 350-0451</address>
      <phone>+81 49 2761270</phone>
      <fax />
      <email>ejmaaki@saitama-med.ac.jp</email>
      <country>Japan</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>